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OBJECTIVE—To examine the prospective association between
objectively measured time spent sedentary and insulin re-
sistance and whether this association is independent of
moderate- and vigorous-intensity physical activity (MVPA) and
other relevant confounders.
RESEARCH DESIGN AND METHODS—This was a popula-
tion-based study (Medical Research Council Ely study) in 376
middle-aged adults (166 men; 210 women) over 5.6 years of
follow-up. Physical activity and sedentary time were measured
objectively by individually calibrated minute-by-minute heart
rate monitoring at both baseline and follow-up. Sedentary time
was calculated as the heart rate observations (in minutes) below
an individually predetermined threshold (ﬂex heart rate) and
expressed as a percentage of total monitored time during waking
hours over 4 days. The percentage of time spent above 1.75 
resting heart rate represented MVPA. Fasting plasma insulin was
used as a surrogate measure of insulin resistance.
RESULTS—Time spent sedentary at baseline was signiﬁcantly
and positively associated with log fasting insulin at follow-up
(0.003, 95% CI 0.0006–0.006, P  0.015) independent of
baseline age, sex, fat mass, fasting insulin, smoking status, and
follow-up time. After further adjustment for MVPA, this associa-
tion was somewhat strengthened (0.004, 95% CI 0.0009–
0.006, P  0.009).
CONCLUSIONS—Time spent sedentary predicts higher levels
of fasting insulin independent of the amount of time spent at
moderate- and vigorous-intensity activity levels. This highlights
the importance of reducing sedentary time in order to improve
metabolic health, possibly in addition to the beneﬁts associated
with a physically active lifestyle. Diabetes 58:1776–1779, 2009
I
nsulin resistance is a precursor of type 2 diabetes
and a major characteristic of the metabolic syn-
drome (1). Hyperinsulinemia and impaired insulin
sensitivity are common clinical ﬁndings yielding
independent health risks, including metabolic, cardiovas-
cular, and neoplastic disorders (2–4).
Several etiological factors have been identiﬁed for im-
paired insulin sensitivity, including genotype, body com-
position, inﬂammation, and lifestyle factors (5–7). Low
levels of physical activity and lack of moderate- and
vigorous-intensity physical activity (MVPA) are associated
with insulin resistance (8,9).
Sedentary time has been linked to various cardiometa-
bolic health outcomes, sometimes independent of overall
physical activity in cross-sectional analyses (10–12). Be-
cause the cardiometabolic consequences are suggested to
be a unique feature in hazardous physical activity behav-
ior, sedentary behavior should be considered distinctively
from physical activity when examining associations with
these health outcomes (13).
A recent prospective analysis suggested that MVPA but
not sedentary time was associated with insulin resistance
in high-risk individuals over a 1-year follow-up period (14).
Further prospective research is needed to examine these
associations and the direction of causality in normal-risk
populations with longer duration of follow-up. Therefore,
the purpose of the present study was to 1) examine the
prospective association between objectively measured
sedentary time and fasting insulin, a marker of insulin
resistance, in healthy middle-aged Caucasian subjects and
2) examine whether this association is independent of
MVPA and other confounding variables.
RESEARCH DESIGN AND METHODS
This study is part of the Medical Research Council Ely study, a prospective
population-based cohort study of the etiology and pathogenesis of type 2
diabetes and related metabolic disorders. Data were collected in 1994–1996
(baseline) and again in 2001–2003 (median follow-up time 5.6 years). A total of
393 participants with complete data on anthropometry, body composition, and
physical activity energy expenditure (PAEE) at both baseline and follow-up
were initially selected (15). Participants with missing data on fasting plasma
insulin, fat mass, smoking status, or MVPA were excluded. Therefore, the
present report comprises 376 (166 male) healthy middle-aged Caucasian
subjects. Missing data were random with respect to body composition and
physical activity at baseline. Ethics permission for the study was granted by
the Cambridge Local Research Committee, and all participants provided
written informed consent.
Plasma insulin, glucose, and confounding variables. Data collection
procedures have been described in detail previously (9,16). In brief, blood
samples were taken after an overnight fast. Plasma insulin and glucose levels
were determined using standardized protocols. Levels of fasting plasma
insulin were used as a surrogate measure for insulin resistance. The ho-
meostasis model assessment of insulin resistance (HOMA-IR) score was
calculated by dividing the product of fasting plasma insulin (microunits per
milliliter) and fasting plasma glucose (millimoles per liter) by 22.5. Anthro-
pometry data were obtained using standardized procedures (9,16). Body
composition was measured by bio-impedance (Bodystat 1500 analyzer; Bodys-
tat, Isle of Man, U.K.). Information on smoking status was self-reported.
Sedentary behavior, physical activity, and aerobic ﬁtness. A standard
valid protocol for measuring energy expenditure was used at baseline and
follow-up (17). The individual relationship between energy expenditure and
heart rate was assessed during rest and exercise according to the ﬂex heart
rate (FHR) method (15–17). At baseline, individual calibration was completed
through a graded cycle ergometer test using indirect calorimetry (P.K.
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1776 DIABETES, VOL. 58, AUGUST 2009Morgan oxygen analyzer). At follow-up, a submaximal graded walking
treadmill test was used. Oxygen consumption and carbon dioxide produc-
tion were measured by indirect calorimetry (Vista XT metabolic system;
Vacumed, Ventura, CA).
Heart rate was monitored on a minute-by-minute basis during the waking
hours over 4 days of free living (Polar Electro, Kemple, Finland). In the
analysis of the free-living heart rate data, sedentary time was assessed as all
heart rate observations (in minutes) below the FHR and expressed as a
percentage of total monitored time. MVPA was deﬁned as the percentage of all
heart rate points above 1.75  resting heart rate (RHR), reported previously
(9). Aerobic ﬁtness (VO2max) was estimated as the oxygen uptake at the
age-predicted maximal heart rate of the extrapolated regression line for each
individual’s oxygen consumption and heart rate relationship. VO2max was
expressed per kilogram of fat-free mass.
Statistical methods. Fasting insulin and HOMA-IR were logarithmically
transformed (ln) in order to normalize skewed distributions. Because these
variables were highly correlated (Pearson’s r  0.99) at both baseline and
follow-up and the results for HOMA-IR and fasting insulin were almost
identical, results are only reported for fasting insulin.
Univariate and multivariate linear regression analysis was used to examine
the associations between men and women, between baseline and follow-up,
and between the percentage of time spent sedentary at baseline and fasting
insulin at follow-up. Confounders included in the multivariate models were
baseline fasting insulin, age, sex, fat mass, smoking status, and duration of
follow-up. To examine whether the association was independent of baseline
MVPA, this variable was added to the model additionally. Collinearity was
controlled for by means of the variance inﬂation factor. Statistical analyses
were conducted using Stata/SE version 10.0 (StataCorp, College Station, TX).
RESULTS
Table 1 shows the descriptive characteristics of the par-
ticipants. Sedentary time was inversely correlated with
MVPA (r  0.34; P  0.001). Table 2 shows the associ-
ations between sedentary time and fasting insulin. No
signiﬁcant interaction effect (sex by sedentary time) on
follow-up fasting insulin was found (P  0.80). Therefore,
results are presented for men and women combined,
adjusting for sex. Percentage of time spent sedentary at
baseline was signiﬁcantly and positively associated with
fasting insulin at follow-up. The unadjusted association
between time spent in MVPA with fasting insulin ap-
proached statistical signiﬁcance. In model 1 (adjusting for
confounders except MVPA), the association between sed-
entary time and fasting insulin at follow-up was attenuated
but remained statistically signiﬁcant. When this model was
reanalyzed with substitution of fat mass for body fat
percentage or waist circumference, the results were es-
sentially unchanged (data not shown). Model 2 (addition-
ally adjusting for time spent in MVPA) showed virtually no
change in the magnitude or direction of the association for
sedentary time. To examine whether the effect of seden-
tary time was also independent of change in fat mass over
the follow-up time, we added change in fat mass to model
2. The association pertained in magnitude and direction
after further adjustment for change in fat mass (0.004,
95% CI 0.001–0.006, P  0.005).
Baseline aerobic ﬁtness was not associated with fol-
low-up fasting insulin (P  0.32) after adjusting for base-
TABLE 1
Descriptive characteristics of participants (n  376) at baseline and follow-up: the Medical Research Council Ely Study, 1994–2003
Total (n  376) Men (n  166) Women (n  210)
Baseline Follow-up Baseline Follow-up Baseline Follow-up
Age (years) 49.4  7.7 55.0  7.9* 49.6  8.1 55.2  8.3* 49.2  7.4 54.8  7.5*
Height (cm) 168.7  8.7 168.5  8.6† 175.7  6.3 175.4  6.2† 163.2  6.0‡ 163.1  6.0‡
Weight (kg) 75.0  13.7 76.3  15.4* 82.8  10.6 83.7  12.0† 68.8  12.7‡ 70.3  15.2*‡
BMI (kg/m
2) 26.3  3.9 26.7  4.6* 26.8  2.9 27.2  3.4* 25.8  4.5 26.4  5.3*
Fat mass (kg) 22.2  7.8 24.4  9.2* 19.1  5.4 21.3  6.4* 24.7  8.5‡ 26.9  10.4*‡
FFM (kg) 52.8  11.5 51.8  11.5* 63.7  6.8 62.4  7.4* 44.1  5.5‡ 43.5  6.0*‡
Waist circumference
(cm) 85.9  12.0 90.5  13.0* 94.3  8.5 98.2  9.7* 79.3  10.2‡ 84.5  12.1*‡
Current smokers (%) 16.8 — 15.1 — 18.1 —
VO2max (ml  kg
FFM
1  min
1) 44.9  11.6 56.5  13.4* 46.3  10.9 58.0  12.2* 43.8  12.0 55.4  14.2*
Flex–heart rate 76.1  10.1 81.5  11.1* 73.1  9.5 77.7  9.8* 78.4  9.9‡ 84.6  11.0*‡
Time spent sedentary
(% of total time) 32.9  20.6 51.7  22.8* 30.7  19.9 47.2  21.5* 34.7  20.9 55.2  23.2*‡
MVPA (% of total
time) 1.9  3.4 1.9  2.2 2.2  3.1 2.2  2.5 1.7  3.6 1.7  2.8
Fasting plasma
insulin (pmol/l) 38.1 (35.9–40.4) 45.6 (42.6–48.7)* 41.7 (38.2–45.6) 52.6 (48.1–57.5)* 35.4 (32.8–38.3) 40.7 (37.0–44.7)*‡
Fasting plasma
glucose (mmol/l) 4.9 (4.8–4.9) 5.4 (5.3–5.4)* 5.0 (4.9–5.1) 5.6 (5.5–5.7)* 4.7 (4.7–4.8)‡ 5.2 (5.1–5.3)*‡
HOMA-IR 1.37 (1.28–1.46) 1.80 (1.67–1.94)* 1.54 (1.40–1.70) 2.19 (1.98–2.41)* 1.24 (1.15–1.35)‡ 1.54 (1.39–1.71)*‡
Data are means  SD or geometric means (95% CI). *P  0.001, †P  0.05 for baseline vs. follow-up, ‡P  0.001 for men vs. women. FFM,
fat-free mass.
TABLE 2
Regression coefﬁcients (95% CI) for the association between
objectively measured sedentary time and MVPA time at baseline
with fasting insulin (log pmol/l) at follow-up in healthy, middle-
aged, Caucasian subjects (n  376)
 (95% CI) PR
2
Unadjusted
Sedentary (%) 0.005 (0.001 to 0.008) 0.005 0.021
MVPA (%) 0.018 (0.04 to 0.002) 0.080 0.008
Model 1
Sedentary (%) 0.003 (0.0006 to 0.006) 0.015 0.439
MVPA (%) 0.002 (0.01 to 0.02) 0.818 0.430
Model 2
Sedentary (%)* 0.004 (0.0009 to 0.006) 0.009 0.441
MVPA (%)† 0.009 (0.007 to 0.02) 0.290 0.441
Models 1 and 2 adjusted for baseline age, sex, fat mass, fasting
insulin, smoking status, and duration of follow-up. *Additionally
adjusted for MVPA. †Additionally adjusted for sedentary time.
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follow-up time. Adjusted geometric means of fasting insu-
lin, stratiﬁed by quartiles of time spent sedentary, are
presented in Fig. 1. This model accounted for 44% of the
variance in fasting insulin. Sedentary time and time spent
in MVPA accounted for 2.1 and 0.8% of the variance,
respectively. Excluding individuals with impaired glucose
tolerance (n  22) at baseline did not materially change
the associations (data not shown).
DISCUSSION
The results from the present study showed that physiolog-
ically measured sedentary time using individual calibra-
tion was associated with hyperinsulinemia measured 5.6
years later in healthy middle-aged Caucasian subjects.
This association was independent of baseline confounders
including age, sex, fat mass, fasting insulin, smoking
status, follow-up time, and MVPA. Similar results were
found when we modeled sedentary time as quartiles.
Moreover, reliability estimates from a repeated-measures
substudy of this cohort suggest that the true association
between behavior and health is likely to be twice as strong
as those observed (18).
Our observations are consistent with previous cross-
sectional ﬁndings using objective measurements of seden-
tary time suggesting that this behavior is associated with
2-h blood glucose (19) and metabolic syndrome features
(11) in adults. Our results extend these previous cross-
sectional observations by suggesting that sedentary time
predicts higher levels of fasting insulin independent of
time spent in MVPA and other confounding factors. This
observation is, however, in contrast to recent prospective
observations in high-risk individuals, where accelerom-
etry-measured MVPA and not sedentary time predicted
insulin resistance at follow-up (14). Differences between
studies are likely explained by differences in methodology
for assessing sedentary time, duration of follow-up, and
population (i.e., age, diabetes risk, and obesity status).
Future studies are needed to determine whether objec-
tively measured subcomponents of physical activity differ-
entially predict insulin resistance and other metabolic
outcomes caused by baseline age, obesity status, and
diabetes risk.
The following study strengths and limitations should be
considered. First, because the present study is observa-
tional, the extent to which causality can be inferred is less
than that for a randomized controlled trial. However, our
prospective study design, the relatively precise measure of
our main exposure variable, and the possibility to control
for many confounding factors support a causal indepen-
dent positive association between sedentary time and the
development of insulin resistance. Second, the use of
individually calibrated heart rate monitoring for measure-
ment of sedentary time is likely to be more accurate
compared with self-report methods. Although this method
is somewhat susceptible to heart rate ﬂuctuations due to
external factors (environmental and emotional inﬂu-
ences), the individually deﬁned FHR will greatly reduce
misclassiﬁcation of time spent sedentary. The thresholds
used for deﬁning sedentary time and MVPA are somewhat
arbitrary. However, these intensity thresholds are feasible
when using heart rate monitoring in large population-
based studies (9,20). Our estimate of time spent sedentary
and at MVPA, based on the FHR and RHR, is adjusted
relative to the ﬁtness level of each individual because RHR
is lower in more ﬁt individuals. This means that our results
may not be directly comparable with results obtained with
other objective methods such as accelerometry. The con-
founding effect of aerobic ﬁtness on our results is likely to
be minimal. Indeed, additional adjustments for aerobic
ﬁtness did not change results for any of the models (data
not shown). Third, the associations observed in this group
of healthy middle-aged Caucasian subjects may not be
generalizable to other populations that differ in age and
physical activity. Volunteers more than 65 years of age at
follow-up were not included due to safety precautions for
the exercise test. However, our results were unchanged
after excluding those with impaired fasting glucose, sug-
gesting that this condition did not explain our ﬁndings.
Fourth, other potential confounders not accounted for in
the analyses, such as genotype, dietary habits, birth
weight, early growth patterns, and pharmaceutical factors,
may explain some of the observed associations. Also,
although we adjusted for MVPA, we could not adjust for
total PAEE because of collinearity. Finally, fasting insulin
is not a direct measure of insulin resistance, but it has
been shown consistently that fasting insulin is a robust
surrogate for insulin resistance and is associated with the
metabolic syndrome, diabetes, and their etiology (21).
Using data from this cohort, we recently showed that
sedentary time at baseline was not signiﬁcantly associated
with a wide range of obesity indicators at follow-up;
interestingly, greater fat mass, waist circumference, and
BMI at baseline signiﬁcantly predicted sedentary time at
follow-up (22). This suggests that sedentary time may be
differentially associated with various health outcomes and
also urges the need for more prospective studies using
objective methods for assessing the dose-response rela-
tionships between various subdimensions of physical ac-
tivity with obesity, insulin resistance, and other chronic
disease risk factors.
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FIG. 1. Geometric means  SE of fasting insulin (follow-up) stratiﬁed
by quartiles of time spent sedentary (baseline) in healthy middle-aged
individuals (n  376). Data are adjusted for baseline age, sex, fat mass,
fasting insulin, smoking status, follow-up time, and time spent at
MVPA.
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implications. In a meta-analysis, Ruige et al. (23) reported
an increased risk of 18% (8–29%) for cardiovascular dis-
eases per increment of 50 pmol/l in fasting insulin. Further,
a recent meta-analysis demonstrated a linear association
between fasting insulin levels and cardiovascular mortality
independent of other risk factors (2).
Pathways through which inactivity can lead to insulin
resistance and its comorbidities include vascular changes.
Vascular and endothelial dysfunction may contribute to
reduced blood ﬂow, decreased peripheral insulin-stimu-
lated glucose uptake, and reduced glucose-stimulated in-
sulin secretion (24). A sedentary lifestyle also has a direct
effect on inactivity-induced factors including deep venous
thrombosis and poor lipid metabolism (25).
In summary, this is the ﬁrst study suggesting that
increased time spent sedentary is prospectively associated
with elevated fasting insulin levels regardless of the
amount of time spent in MVPA in healthy middle-aged
adults. From a public health perspective, these ﬁndings
urge the need for recommendations aimed at reducing
sedentary time in addition to those aimed at increasing
MVPA.
ACKNOWLEDGMENTS
The Medical Research Council (MRC) U.K. provided fund-
ing for the MRC Ely study.
No potential conﬂicts of interest relevant to this article
were reported.
We are grateful to the volunteers, who gave their time;
to Susie Hennings, Sue Emms, and Ema Lucia De Rolfe,
who coordinated the study and collected data; to Kate
Westgate, who assisted with the analysis of physical
activity data; and to Stephen Sharp, who provided statis-
tical advice.
REFERENCES
1. Balkau B, Charles MA, Drivsholm T, Borch-Johnsen K, Wareham N, Yudkin
JS, Morris R, Zavaroni I, van Dam R, Feskins E, Gabriel R, Diet M, Nilsson
P, Hedblad B. Frequency of the WHO metabolic syndrome in European
cohorts, and an alternative deﬁnition of an insulin resistance syndrome.
Diabetes Metab 2002;28:364–376
2. Hu G, Qiao Q, Tuomilehto J, Eliasson M, Feskens EJ, Pyorala K. Plasma
insulin and cardiovascular mortality in non-diabetic European men and
women: a meta-analysis of data from eleven prospective studies. Diabeto-
logia 2004;47:1245–1256
3. Li C, Ford ES, McGuire LC, Mokdad AH, Little RR, Reaven GM. Trends in
hyperinsulinemia among nondiabetic adults in the U.S. Diabetes Care
2006;29:2396–2402
4. Flood A, Mai V, Pfeiffer R, Kahle L, Remaley AT, Lanza E, Schatzkin A.
Elevated serum concentrations of insulin and glucose increase risk of
recurrent colorectal adenomas. Gastroenterology 2007;133:1423–1429
5. Zeggini E, Scott LJ, Saxena R, Voight BF, Marchini JL, Hu T, de Bakker PI,
Abecasis GR, Almgren P, Andersen G, Ardlie K, Bostrom KB, Bergman RN,
Bonnycastle LL, Borch-Johnsen K, Burtt NP, Chen H, Chines PS, Daly MJ,
Deodhar P, Ding CJ, Doney AS, Duren WL, Elliott KS, Erdos MR, Frayling
TM, Freathy RM, Gianniny L, Grallert H, Grarup N, Groves CJ, Guiducci C,
Hansen T, Herder C, Hitman GA, Hughes TE, Isomaa B, Jackson AU,
Jorgensen T, Kong A, Kubalanza K, Kuruvilla FG, Kuusisto J, Langenberg
C, Lango H, Lauritzen T, Li Y, Lindgren CM, Lyssenko V, Marvelle AF,
Meisinger C, Midthjell K, Mohlke KL, Morken MA, Morris AD, Narisu N,
Nilsson P, Owen KR, Palmer CN, Payne F, Perry JR, Pettersen E, Platou C,
Prokopenko I, Qi L, Qin L, Rayner NW, Rees M, Roix JJ, Sandbaek A,
Shields B, Sjogren M, Steinthorsdottir V, Stringham HM, Swift AJ, Thorle-
ifsson G, Thorsteinsdottir U, Timpson NJ, Tuomi T, Tuomilehto J, Walker
M, Watanabe RM, Weedon MN, Willer CJ, Illig T, Hveem K, Hu FB, Laakso
M, Stefansson K, Pedersen O, Wareham NJ, Barroso I, Hattersley AT,
Collins FS, Groop L, McCarthy MI, Boehnke M, Altshuler D. Meta-
analysis of genome-wide association data and large-scale replication
identiﬁes additional susceptibility loci for type 2 diabetes. Nat Genet
2008;40:638–645
6. Mazzali G, Di Francesco V, Zoico E, Fantin F, Zamboni G, Benati C,
Bambara V, Negri M, Bosello O, Zamboni M. Interrelations between fat
distribution, muscle lipid content, adipocytokines, and insulin resistance:
effect of moderate weight loss in older women. Am J Clin Nutr 2006;84:
1193–1199
7. Festa A, D’Agostino R, Jr, Tracy RP, Haffner SM. Elevated levels of
acute-phase proteins and plasminogen activator inhibitor-1 predict the
development of type 2 diabetes: the Insulin Resistance Atherosclerosis
Study. Diabetes 2002;51:1131–1137
8. Mayer-Davis EJ, D’Agostino R Jr, Karter AJ, Haffner SM, Rewers MJ, Saad
M, Bergman RN. Intensity and amount of physical activity in relation to
insulin sensitivity: the Insulin Resistance Atherosclerosis Study. JAMA
1998;279:669–674
9. Assah FK, Brage S, Ekelund U, Wareham NJ. The association of intensity
and overall level of physical activity energy expenditure with a marker of
insulin resistance. Diabetologia 2008;51:1399–1407
10. Dunstan DW, Salmon J, Owen N, Armstrong T, Zimmet PZ, Welborn TA,
Cameron AJ, Dwyer T, Jolley D, Shaw JE. Associations of TV viewing and
physical activity with the metabolic syndrome in Australian adults. Diabe-
tologia 2005;48:2254–2261
11. Healy GN, Wijndaele K, Dunstan DW, Shaw JE, Salmon J, Zimmet PZ,
Owen N. Objectively measured sedentary time, physical activity, and
metabolic risk: the Australian Diabetes, Obesity and Lifestyle Study
(AusDiab). Diabetes Care 2008;31:369–371
12. Wijndaele K, Duvigneaud N, Matton L, Duquet W, Delecluse C, Thomis M,
Beunen G, Lefevre J, Philippaerts RM. Sedentary behaviour, physical
activity and a continuous metabolic syndrome risk score in adults. Eur
J Clin Nutr 2009;63:421–429
13. Owen N, Leslie E, Salmon J, Fotheringham MJ. Environmental determi-
nants of physical activity and sedentary behavior. Exerc Sport Sci Rev
2000;28:153–158
14. Ekelund U, Brage S, Grifﬁn S, Wareham N. Objectively measured moder-
ate- and vigorous-intensity physical activity but not sedentary time predict
insulin resistance in high-risk individuals. Diabetes Care 2009;32:1081–
1086
15. Ekelund U, Franks PW, Sharp S, Brage S, Wareham NJ. Increase in
physical activity energy expenditure is associated with reduced metabolic
risk independent of change in fatness and ﬁtness. Diabetes Care 2007;30:
2101–2106
16. Ekelund U, Brage S, Franks PW, Hennings S, Emms S, Wareham NJ.
Physical activity energy expenditure predicts progression toward the
metabolic syndrome independently of aerobic ﬁtness in middle-aged
healthy Caucasians: the Medical Research Council Ely Study. Diabetes
Care 2005;28:1195–1200
17. Livingstone MB, Prentice AM, Coward WA, Ceesay SM, Strain JJ, McKenna
PG, Nevin GB, Barker ME, Hickey RJ. Simultaneous measurement of
free-living energy expenditure by the doubly labeled water method and
heart-rate monitoring. Am J Clin Nutr 1990;52:59–65
18. Wareham NJ, Wong MY, Day N. Glucose intolerance and physical inactiv-
ity: the relative importance of low habitual energy expenditure and
cardiorespiratory ﬁtness. Am J Epidemiol 2000;152:132–139
19. Healy GN, Dunstan DW, Salmon J, Cerin E, Shaw JE, Zimmet PZ, Owen N.
Objectively measured light-intensity physical activity is independently
associated with 2-h plasma glucose. Diabetes Care 2007;30:1384–1389
20. Wareham NJ, Hennings SJ, Prentice AM, Day NE. Feasibility of heart-rate
monitoring to estimate total level and pattern of energy expenditure in a
population-based epidemiological study: the Ely Young Cohort Feasibility
Study 1994–5. Br J Nutr 1997;78:889–900
21. Vaccaro O, Masulli M, Cuomo V, Rivellese AA, Uusitupa M, Vessby B,
Hermansen K, Tapsell L, Riccardi G. Comparative evaluation of simple
indices of insulin resistance. Metabolism 2004;53:1522–1526
22. Ekelund U, Brage S, Besson H, Sharp S, Wareham NJ. Time spent being
sedentary and weight gain in healthy adults: reverse or bidirectional
causality? Am J Clin Nutr 2008;88:612–617
23. Ruige JB, Assendelft WJ, Dekker JM, Kostense PJ, Heine RJ, Bouter LM.
Insulin and risk of cardiovascular disease: a meta-analysis. Circulation
1998;97:996–1001
24. Houmard JA, Tanner CJ, Slentz CA, Duscha BD, McCartney JS, Kraus WE.
Effect of the volume and intensity of exercise training on insulin sensitiv-
ity. J Appl Physiol 2004;96:101–106
25. Hamilton MT, Hamilton DG, Zderic TW. Role of low energy expenditure
and sitting in obesity, metabolic syndrome, type 2 diabetes, and cardio-
vascular disease. Diabetes 2007;56:2655–2667
H.J.F. HELMERHORST AND ASSOCIATES
DIABETES, VOL. 58, AUGUST 2009 1779